Trials / Completed
CompletedNCT01948869
Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis
An Investigator-blinded, Randomized, Monocentre, 3-arm, Pilot Trial to Compare the Efficacy and Safety of Two Topical Medical Devices in Patients With Mild to Moderate Atopic Dermatitis in an Intra-individual Comparison With Untreated Skin
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The study shall explore whether treatment of atopic dermatitis is equally effective with respect to a marketed medical device and a new medical device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Phoenix II (BAY81-2996) | |
| DEVICE | Phoenix I (BAY81-2996) |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-09-24
- Last updated
- 2014-08-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01948869. Inclusion in this directory is not an endorsement.